NeuroPace Receivables 2020-2025 | NPCE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NeuroPace receivables from 2020 to 2025. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NeuroPace receivables from 2020 to 2025. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$185.9B
Thermo Fisher Scientific (TMO)	$156.6B
Edwards Lifesciences (EW)	$44.9B
Alcon (ALC)	$43.1B
IDEXX Laboratories (IDXX)	$41.4B
DexCom (DXCM)	$32.9B
IQVIA Holdings (IQV)	$27.8B
Mettler-Toledo (MTD)	$24.8B
STERIS (STE)	$22.2B
SONOVA HOLDING (SONVY)	$17.4B
Waters (WAT)	$17.1B
Hologic (HOLX)	$14.3B
Sysmex ADR (SSMXY)	$10.4B
Penumbra (PEN)	$8.9B
Masimo (MASI)	$8.4B
Globus Medical (GMED)	$7.6B
Glaukos (GKOS)	$5.6B
Teleflex (TFX)	$4.9B
Integer Holdings (ITGR)	$3.9B
TransMedics (TMDX)	$3.7B
PROCEPT BioRobotics (PRCT)	$3.2B
LivaNova (LIVN)	$2.3B
Elekta AB (EKTAY)	$1.9B
Nihon Kohden (NHNKY)	$1.9B
Veracyte (VCYT)	$1.8B
Alphatec Holdings (ATEC)	$1.5B
Artivion (AORT)	$1.3B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B
Pulse Biosciences (PLSE)	$1B